Guidelines For Clinical Practice
Copyright ©2010 Baishideng.
World J Hepatol. Mar 27, 2010; 2(3): 103-113
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Figure 1
Figure 1 Schematic representation of HCC carcinogenesis.
Figure 2
Figure 2 Molecularly targeted agents of potential interest in HCC and relative targets. A: EGFR and VEGF/VEGFR pathways; B: The MAP-kinase and PI3K/mTOR pathways.